{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T00:56:44Z","timestamp":1788742604087,"version":"build-2803163510"},"reference-count":81,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,4]],"date-time":"2024-11-04T00:00:00Z","timestamp":1730678400000},"content-version":"vor","delay-in-days":34,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.ejmech.2024.116592","type":"journal-article","created":{"date-parts":[[2024,6,17]],"date-time":"2024-06-17T11:32:57Z","timestamp":1718623977000},"page":"116592","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Novel neuroprotective 5,6-dihydropyrido[2\u2032,1':2,3]imidazo[4,5-c]quinoline derivatives acting through cholinesterase inhibition and CB2 signaling modulation"],"prefix":"10.1016","volume":"276","author":[{"given":"Sushovan","family":"Jena","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominik","family":"V\u00edtek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Kvasnicov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0160\u00e1rka","family":"\u0160t\u011bp\u00e1nkov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miroslav","family":"Strnad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7378-8941","authenticated-orcid":false,"given":"Ji\u0159\u00ed","family":"Voller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaushik","family":"Chanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2024.116592_bib1","doi-asserted-by":"crossref","first-page":"80","DOI":"10.3389\/fnins.2018.00080","article-title":"Mechanisms of \u03b1-synuclein induced synaptopathy in Parkinson's disease","volume":"12","author":"Bridi","year":"2018","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.ejmech.2024.116592_bib2","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1002\/mds.26562","article-title":"Lysosomal dysfunction and \u03b1-synuclein aggregation in Parkinson's disease: diagnostic links","volume":"31","author":"Moors","year":"2016","journal-title":"Mov. Disord."},{"key":"10.1016\/j.ejmech.2024.116592_bib3","doi-asserted-by":"crossref","first-page":"236","DOI":"10.3389\/fnmol.2018.00236","article-title":"Oxidative stress in Parkinson's disease: a systematic review and meta-analysis","volume":"11","author":"Wei","year":"2018","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.ejmech.2024.116592_bib4","doi-asserted-by":"crossref","first-page":"103","DOI":"10.5607\/en.2015.24.2.103","article-title":"Mitochondrial dysfunction in Parkinson's disease","volume":"24","author":"Moon","year":"2015","journal-title":"Exp. Neurobiol."},{"key":"10.1016\/j.ejmech.2024.116592_bib5","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s40035-015-0042-0","article-title":"Neuroinflammation in Parkinson's disease and its potential as therapeutic target","volume":"4","author":"Wang","year":"2015","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.ejmech.2024.116592_bib6","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1600-0404.1983.tb01513.x","article-title":"Problems associated with long-term levodopa treatment of Parkinson's disease","volume":"95","author":"Rinne","year":"1983","journal-title":"Acta Neurol. Scand. Suppl."},{"key":"10.1016\/j.ejmech.2024.116592_bib7","doi-asserted-by":"crossref","first-page":"277","DOI":"10.5694\/mja2.50224","article-title":"Updates and advances in the treatment of Parkinson disease","volume":"211","author":"Hayes","year":"2019","journal-title":"Med. J. Aust."},{"key":"10.1016\/j.ejmech.2024.116592_bib8","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2202-13-38","article-title":"Riluzole neuroprotection in a Parkinson's disease model involves suppression of reactive astrocytosis but not GLT-1 regulation","volume":"13","author":"Carbone","year":"2012","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.ejmech.2024.116592_bib9","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1001\/jama.291.3.358","article-title":"Neuroprotection in Parkinson disease: mysteries, myths, and misconceptions","volume":"291","author":"Schapira","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.ejmech.2024.116592_bib10","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1124\/jpet.105.090365","article-title":"Unequal neuroprotection afforded by the acetylcholinesterase inhibitors galantamine, donepezil, and rivastigmine in SH-SY5Y neuroblastoma cells: role of nicotinic receptors","volume":"315","author":"Arias","year":"2005","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejmech.2024.116592_bib11","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1007\/s12640-009-9040-2","article-title":"Additive protective effects of donepezil and nicotine against salsolinol-induced cytotoxicity in SH-SY5Y cells","volume":"16","author":"Das","year":"2009","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.ejmech.2024.116592_bib12","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1093\/abbs\/gmx082","article-title":"Neuroprotective effect of deferoxamine on N-methyl-d-aspartate-induced excitotoxicity in RGC-5 cells","volume":"49","author":"Tian","year":"2017","journal-title":"Acta Biochim. Biophys. Sin."},{"key":"10.1016\/j.ejmech.2024.116592_bib13","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1212\/WNL.63.7_suppl_2.S13","article-title":"Preclinical evidence for neuroprotection with monoamine oxidase-B inhibitors in Parkinson's disease","volume":"63","author":"Jenner","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.ejmech.2024.116592_bib14","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1017\/S0317167100041469","article-title":"A rationale for dopamine agonists as primary therapy for Parkinson's disease","volume":"19","author":"Olanow","year":"2015","journal-title":"Can. J. Neurol. Sci."},{"key":"10.1016\/j.ejmech.2024.116592_bib15","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1212\/WNL.56.12.1712","article-title":"Freezing of gait in PD: prospective assessment in the DATATOP cohort","volume":"56","author":"Giladi","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.ejmech.2024.116592_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.108085","article-title":"New hopes for disease modification in Parkinson's Disease","volume":"171","author":"Poewe","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejmech.2024.116592_bib17","doi-asserted-by":"crossref","first-page":"50","DOI":"10.2174\/1389200217666160709204826","article-title":"Natural products combating neurodegeneration: Parkinson's disease","volume":"18","author":"Solayman","year":"2017","journal-title":"Curr. Drug Metabol."},{"key":"10.1016\/j.ejmech.2024.116592_bib18","first-page":"428","article-title":"Effects of cholinesterase inhibitors in Parkinson's disease dementia: a review of clinical data, CNS neurosci","volume":"17","author":"van Laar","year":"2011","journal-title":"Therapy"},{"key":"10.1016\/j.ejmech.2024.116592_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuro.2022.02.006","article-title":"Butyrylcholinesterase in SH-SY5Y human neuroblastoma cells","volume":"90","author":"Onder","year":"2022","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.ejmech.2024.116592_bib20","doi-asserted-by":"crossref","first-page":"9302","DOI":"10.1021\/acs.jmedchem.1c00534","article-title":"Selective pseudo-irreversible butyrylcholinesterase inhibitors transferring antioxidant moieties to the enzyme show pronounced neuroprotective efficacy in vitro and in vivo in an Alzheimer's disease mouse model","volume":"64","author":"Scheiner","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116592_bib21","doi-asserted-by":"crossref","DOI":"10.1038\/srep39495","article-title":"Development of an in-vivo active reversible butyrylcholinesterase inhibitor","volume":"6","author":"Ko\u0161ak","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2024.116592_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114510","article-title":"A highly effective and stable butyrylcholinesterase inhibitor with multi-faceted neuroprotection and cognition improvement","volume":"239","author":"Li","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116592_bib23","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1097\/NEN.0b013e31823cc7a6","article-title":"Butyrylcholinesterase is associated with \u03b2-amyloid plaques in the transgenic APPSWE\/PSEN1dE9 mouse model of Alzheimer disease","volume":"71","author":"Darvesh","year":"2012","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.ejmech.2024.116592_bib24","doi-asserted-by":"crossref","first-page":"9809","DOI":"10.3390\/ijms15069809","article-title":"Inhibitors of acetylcholinesterase and butyrylcholinesterase meet immunity","volume":"15","author":"Pohanka","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2024.116592_bib25","doi-asserted-by":"crossref","first-page":"17213","DOI":"10.1073\/pnas.0508575102","article-title":"Selective butyrylcholinesterase inhibition elevates brain acetylcholine, augments learning and lowers Alzheimer beta-amyloid peptide in rodent","volume":"102","author":"Greig","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejmech.2024.116592_bib26","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.tips.2004.12.010","article-title":"A preclinical view of cholinesterase inhibitors in neuroprotection: do they provide more than symptomatic benefits in Alzheimer's disease?","volume":"26","author":"Francis","year":"2005","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejmech.2024.116592_bib27","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2016.00406","article-title":"Targeting cannabinoid CB2 receptors in the central nervous system. Medicinal chemistry approaches with focus on neurodegenerative disorders","volume":"10","author":"Navarro","year":"2016","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.ejmech.2024.116592_bib28","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s13024-015-0012-0","article-title":"Promising cannabinoid-based therapies for Parkinson's disease: motor symptoms to neuroprotection","volume":"10","author":"More","year":"2015","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.ejmech.2024.116592_bib29","doi-asserted-by":"crossref","first-page":"512","DOI":"10.3390\/molecules23030512","article-title":"Neuroprotective effects and mechanisms of tea bioactive components in neurodegenerative diseases","volume":"23","author":"Chen","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2024.116592_bib30","doi-asserted-by":"crossref","first-page":"360","DOI":"10.2174\/0929867323666151127201249","article-title":"Neuroprotective activities of marine natural products from marine sponges","volume":"23","author":"Alghazwi","year":"2016","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116592_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2021.128312","article-title":"Neuroprotective effects of 2-heptyl-3-hydroxy-4-quinolone in HT22 mouse hippocampal neuronal cells","volume":"49","author":"Selvaraj","year":"2021","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2024.116592_bib32","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1021\/jm950323j","article-title":"Structure\u2212Activity relationships in a series of 2(1H)-Quinolones bearing different acidic function in the 3-position: 6,7-dichloro-2(1H)-oxoquinoline-3-phosphonic acid, a new potent and selective AMPA\/kainate antagonist with neuroprotective properties","volume":"39","author":"Desos","year":"1996","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116592_bib33","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1021\/jm2012563","article-title":"Chemical modification of the multitarget neuroprotective compound fisetin","volume":"55","author":"Chiruta","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116592_bib34","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1021\/jm050467q","article-title":"Novel 4-Oxo-1,4-dihydroquinoline-3-carboxamide derivatives as new CB2 cannabinoid receptors agonists: synthesis, pharmacological properties and molecular modeling","volume":"49","author":"Stern","year":"2006","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116592_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejmech.2010.08.054","article-title":"Synthesis, biological assessment and molecular modeling of new dihydroquinoline-3-carboxamides and dihydroquinoline-3-carbohydrazide derivatives as cholinesterase inhibitors, and Ca channel antagonists","volume":"46","author":"Tomassoli","year":"2011","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116592_bib36","first-page":"420","article-title":"In vitro and in vivo pharmacological characterization of JTE-907, a novel selective ligand for cannabinoid CB2 receptor","volume":"296","author":"Iwamura","year":"2001","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejmech.2024.116592_bib37","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1055\/a-2102-1192","article-title":"One-pot telescopic approach to synthesize disubstituted benzimidazoles in deep eutectic solvent","volume":"56","author":"Das","year":"2024","journal-title":"Synthesis"},{"key":"10.1016\/j.ejmech.2024.116592_bib38","doi-asserted-by":"crossref","first-page":"3249","DOI":"10.1039\/D4OB00075G","article-title":"Synthetic access to diverse thiazetidines via a one-pot microwave assisted telescopic approach and their interaction with biomolecules","volume":"22","author":"Rao","year":"2024","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.ejmech.2024.116592_bib39","doi-asserted-by":"crossref","first-page":"3280","DOI":"10.1039\/D0NJ05835A","article-title":"An expeditious microwave assisted one-pot sequential route to pyrido fused imidazo[4,5-c] quinolines in green media","volume":"45","author":"Rao","year":"2021","journal-title":"New J. Chem."},{"key":"10.1016\/j.ejmech.2024.116592_bib40","unstructured":"Final product 5f was crystallized by slow evaporation of a solution of ethyl acetate\u2212hexane (1:1, v\/v) at room temperature. Crystal data: C22H22F3N3O2, M = 417.43 Triclinic, space group P1, The crystal data has been deposited at Cambridge Crystallographic Data Centre [CCDC No. 2330777]. Copies of the data can be obtained free of charge via a www.ccdc.cam.ac.uk\/data_request\/cif.in."},{"key":"10.1016\/j.ejmech.2024.116592_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsbmb.2022.106194","article-title":"Ring-fused 3\u03b2-acetoxyandrost-5-enes as novel neuroprotective agents with cholinesterase inhibitory properties","volume":"225","author":"Gonzalez","year":"2023","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.ejmech.2024.116592_bib42","doi-asserted-by":"crossref","first-page":"3008","DOI":"10.1021\/acschemneuro.0c00328","article-title":"Neuroprotective and anti-neuroinflammatory properties of ebselen derivatives and their potential to inhibit neurodegeneration","volume":"11","author":"Landgraf","year":"2020","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejmech.2024.116592_bib43","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1006\/exnr.2000.7516","article-title":"The antioxidant ebselen prevents neurotoxicity and clinical symptoms in a primate model of Parkinson's disease","volume":"166","author":"Moussaoui","year":"2001","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.ejmech.2024.116592_bib44","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21217809","article-title":"High-resolution respirometry reveals MPP(+) mitochondrial toxicity mechanism in a cellular model of Parkinson's disease","volume":"21","author":"Risiglione","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2024.116592_bib45","article-title":"MPP+ induces necrostatin-1- and ferrostatin-1-sensitive necrotic death of neuronal SH-SY5Y cells","volume":"3","author":"Ito","year":"2017","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ejmech.2024.116592_bib46","doi-asserted-by":"crossref","first-page":"6799","DOI":"10.1074\/jbc.M114.631556","article-title":"Changes in neuronal dopamine homeostasis following 1-methyl-4-phenylpyridinium (MPP+) exposure","volume":"290","author":"Choi","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2024.116592_bib47","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13024-017-0149-0","article-title":"The SH-SY5Y cell line in Parkinson's disease research: a systematic review","volume":"12","author":"Xicoy","year":"2017","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.ejmech.2024.116592_bib48","doi-asserted-by":"crossref","first-page":"e756","DOI":"10.1002\/iid3.756","article-title":"Knockdown of SEMA7A alleviates MPP+-induced apoptosis and inflammation in BV2 microglia via PPAR-\u03b3 activation and MAPK inactivation","volume":"11","author":"Qi","year":"2023","journal-title":"Immunity, Inflammation and Disease"},{"key":"10.1016\/j.ejmech.2024.116592_bib49","doi-asserted-by":"crossref","DOI":"10.1002\/jcb.25376","article-title":"The neuroprotective role of insulin against MPP+\u2010Induced Parkinson's disease in differentiated SH\u2010SY5Y cells","volume":"117","author":"Ramalingam","year":"2016","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.ejmech.2024.116592_bib50","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/1742-2094-8-129","article-title":"Generation of reactive oxygen species in 1-methyl-4-phenylpyridinium (MPP+) treated dopaminergic neurons occurs as an NADPH oxidase-dependent two-wave cascade","volume":"8","author":"Zawada","year":"2011","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.ejmech.2024.116592_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113168","article-title":"Novel pentacyclic triterpenes exhibiting strong neuroprotective activity in SH-SY5Y cells in salsolinol- and glutamate-induced neurodegeneration models","volume":"213","author":"Gonzalez","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116592_bib52","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.3390\/ijms14022334","article-title":"Cell survival and apoptosis signaling as therapeutic target for cancer: marine bioactive compounds","volume":"14","author":"Kalimuthu","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2024.116592_bib53","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/s41419-020-2724-5","article-title":"Autophagy as a modulator of cell death machinery","volume":"11","author":"Noguchi","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ejmech.2024.116592_bib54","doi-asserted-by":"crossref","first-page":"e312","DOI":"10.1038\/cddis.2012.46","article-title":"Impaired mitochondrial biogenesis contributes to depletion of functional mitochondria in chronic MPP+ toxicity: dual roles for ERK1\/2","volume":"3","author":"Zhu","year":"2012","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ejmech.2024.116592_bib55","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232315255","article-title":"Effects of apamin on MPP+-Induced calcium overload and neurotoxicity by targeting CaMKII\/ERK\/p65\/STAT3 signaling pathways in dopaminergic neuronal cells","author":"Park","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2024.116592_bib56","volume":"23","author":"Park","year":"2022"},{"key":"10.1016\/j.ejmech.2024.116592_bib57","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1124\/jpet.108.136358","article-title":"Extracellular signal-regulated kinase activation mediates mitochondrial dysfunction and necrosis induced by hydrogen peroxide in renal proximal tubular cells","volume":"325","author":"Zhuang","year":"2008","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejmech.2024.116592_bib58","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcad207","article-title":"Effects of cholinesterase inhibition on attention and working memory in Lewy body dementias","volume":"5","author":"Fallon","year":"2023","journal-title":"Brain Commun."},{"key":"10.1016\/j.ejmech.2024.116592_bib59","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1001\/jamaneurol.2023.1835","article-title":"Cholinesterase inhibitors for treatment of psychotic symptoms in alzheimer disease and Parkinson disease: a meta-analysis","volume":"80","author":"d'Angremont","year":"2023","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.ejmech.2024.116592_bib60","doi-asserted-by":"crossref","first-page":"e2313","DOI":"10.1212\/WNL.0000000000201161","article-title":"Effect of cholinesterase inhibitors on mortality in patients with dementia","volume":"99","author":"Truong","year":"2022","journal-title":"Neurology"},{"key":"10.1016\/j.ejmech.2024.116592_bib61","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/j.bmc.2013.12.066","article-title":"Synthesis and biological evaluation of a new series of ebselen derivatives as glutathione peroxidase (GPx) mimics and cholinesterase inhibitors against Alzheimer's disease","volume":"22","author":"Luo","year":"2014","journal-title":"Biorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116592_bib62","doi-asserted-by":"crossref","DOI":"10.1038\/celldisc.2015.2","article-title":"A novel role for synaptic acetylcholinesterase as an apoptotic deoxyribonuclease","volume":"1","author":"Du","year":"2015","journal-title":"Cell Discovery"},{"key":"10.1016\/j.ejmech.2024.116592_bib63","doi-asserted-by":"crossref","first-page":"20851","DOI":"10.1074\/jbc.M111.335273","article-title":"Cannabinoid receptors CB1 and CB2 form functional heteromers in brain","volume":"287","author":"Call\u00e9n","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2024.116592_bib64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.prostaglandins.2012.11.003","article-title":"Involvement of ERK1\/2, cPLA2 and NF-\u03baB in microglia suppression by cannabinoid receptor agonists and antagonists","volume":"100\u2013101","author":"Ribeiro","year":"2013","journal-title":"Prostag. Other Lipid Mediat."},{"key":"10.1016\/j.ejmech.2024.116592_bib65","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1093\/eurheartj\/ehr449","article-title":"The activation of the cannabinoid receptor type 2 reduces neutrophilic protease-mediated vulnerability in atherosclerotic plaques","volume":"33","author":"Montecucco","year":"2012","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ejmech.2024.116592_bib66","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1203\/01.pdr.0000228839.00122.6c","article-title":"Characterization of the neuroprotective effect of the cannabinoid agonist WIN-55212 in an in vitro model of hypoxic-ischemic brain damage in newborn rats","volume":"60","author":"Fern\u00e1ndez-L\u00f3pez","year":"2006","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.ejmech.2024.116592_bib67","article-title":"Neuroprotective effect of JZL184 in MPP-treated SH-SY5Y cells through CB receptors","volume":"53","author":"Aymerich","year":"2015","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.ejmech.2024.116592_bib68","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.neuropharm.2012.05.013","article-title":"WIN55212-2 attenuates amyloid-beta-induced neuroinflammation in rats through activation of cannabinoid receptors and PPAR-\u03b3 pathway","volume":"63","author":"Fakhfouri","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejmech.2024.116592_bib69","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1002\/dneu.20609","article-title":"PI3 kinase\/Akt activation mediates estrogen and IGF\u20101 nigral DA neuronal neuroprotection against a unilateral rat model of Parkinson's disease","volume":"68","author":"Quesada","year":"2008","journal-title":"Dev. Neurobiol."},{"key":"10.1016\/j.ejmech.2024.116592_bib70","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.ccr.2008.11.003","article-title":"Akt determines replicative senescence and oxidative or oncogenic premature senescence and sensitizes cells to oxidative apoptosis","volume":"14","author":"Nogueira","year":"2008","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ejmech.2024.116592_bib71","doi-asserted-by":"crossref","first-page":"39001","DOI":"10.1074\/jbc.M007154200","article-title":"Oncogenic ras mediates apoptosis in response to protein kinase C inhibition through the generation of reactive oxygen species","volume":"275","author":"Liou","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2024.116592_bib72","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1242\/jcs.009530","article-title":"Akt-mediated phosphorylation of CDK2 regulates its dual role in cell cycle progression and apoptosis","volume":"121","author":"Maddika","year":"2008","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.ejmech.2024.116592_bib73","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.ccr.2006.08.009","article-title":"Selective killing of oncogenically transformed cells through a ROS-mediated mechanism by \u03b2-phenylethyl isothiocyanate","volume":"10","author":"Trachootham","year":"2006","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ejmech.2024.116592_bib74","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26020361","article-title":"Cytokinin plant hormones have neuroprotective activity in in vitro models of Parkinson's disease","author":"Gonzalez","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2024.116592_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2019.107903","article-title":"In vitro response and gene expression of human retinal M\u00fcller cells treated with different anti-VEGF drugs","volume":"191","author":"C\u00e1ceres-del-Carpio","year":"2020","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.ejmech.2024.116592_bib76","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.2144\/03345dd02","article-title":"One-step cellular Caspase-3\/7 assay","volume":"34","author":"Carrasco","year":"2003","journal-title":"Biotechniques"},{"key":"10.1016\/j.ejmech.2024.116592_bib77","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.jsbmb.2016.03.017","article-title":"Structure activity relationship studies on cytotoxicity and the effects on steroid receptors of AB-functionalized cholestanes","volume":"159","author":"R\u00e1rov\u00e1","year":"2016","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.ejmech.2024.116592_bib78","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsbmb.2022.106161","article-title":"Effect of modification of betulinic acid at the C3-carbon atom of homolupane triterpenoids on the antiproliferative activity in vitro","volume":"224","author":"R\u00e1rov\u00e1","year":"2022","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.ejmech.2024.116592_bib79","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.ejmech.2024.116592_bib80","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.ejmech.2024.116592_bib81","first-page":"1","article-title":"PAST: paleontological statistics software package for education and data analysis","volume":"4","author":"Hammer","year":"2001","journal-title":"Palaeontol. Electron."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523424004720?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523424004720?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,4]],"date-time":"2024-11-04T11:47:38Z","timestamp":1730720858000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523424004720"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":81,"alternative-id":["S0223523424004720"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2024.116592","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel neuroprotective 5,6-dihydropyrido[2\u2032,1':2,3]imidazo[4,5-c]quinoline derivatives acting through cholinesterase inhibition and CB2 signaling modulation","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2024.116592","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"116592"}}